The Effect of Miconazole on Vulvo‐Vaginal Candidosis in Pregnant and Non‐pregnant Women and their Partners
- 1 November 1976
- journal article
- clinical trial
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 14 (6) , 537-540
- https://doi.org/10.1002/j.1879-3479.1976.tb00103.x
Abstract
Brundin, J. (Dept. of Obstetrics and Gynecology, Danderyd's Hospital, Danderyd, Sweden). The effect of Miconazole on vulvo‐vaginal candidosis in pregnant and non‐pregnant women and their partners.Int J Gynaecol Obstet 14: 537–540, 1976.Miconazole cream1 (Daktar vaginal cream 2%, Leo) given for 12–14 days was tested in 85 subjects with positive vaginal Candida culture. Eighty percent of the patients were pregnant. Healing was observed in 93% of the cases. Treatment of the sexual partner did not influence the therapeutic effect.Keywords
This publication has 8 references indexed in Scilit:
- MiconazoleDrugs, 1975
- MONISTAT: A new fungicide for treatment of vulvovaginal candidiasisAmerican Journal of Obstetrics and Gynecology, 1974
- Recent developments in antimycotic chemotherapyInfection, 1974
- Studies on the Mechanism of Action of Miconazole: Effect of Miconazole on Respiration and Cell Permeability of Candida albicansAntimicrobial Agents and Chemotherapy, 1974
- Systemic antifungal potential, safety, biotransport and transformation of micronazole nitrateEuropean Journal of Clinical Pharmacology, 1972
- Miconazole (R 14 889) in the treatment of vaginal candidosis. A multicentric trial in gynecological practiceEuropean Journal of Obstetrics & Gynecology, 1972
- Miconazole, a Broad-Spectrum Antimycotic Agent with Antibacterial ActivityChemotherapy, 1972
- Preparation and antimycotic properties of derivatives of 1-phenethylimidazoleJournal of Medicinal Chemistry, 1969